60 Degrees Pharmaceuticals (SXTPW) Competitors $0.10 +0.05 (+99.00%) As of 08/5/2025 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock SXTPW vs. ATNFW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. 60 Degrees Pharmaceuticals vs. Its Competitors 180 Life Sciences Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Is SXTPW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets 60 Degrees PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media refer more to SXTPW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for 60 Degrees Pharmaceuticals. 180 Life Sciences' average media sentiment score of 0.95 beat 60 Degrees Pharmaceuticals' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment 60 Degrees Pharmaceuticals Neutral 180 Life Sciences Positive Which has preferable earnings and valuation, SXTPW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio60 Degrees Pharmaceuticals$665.45KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Summary180 Life Sciences beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTPW vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$137.01M$5.59B$9.53BDividend YieldN/A3.74%4.73%4.14%P/E RatioN/A3.7528.9123.88Price / SalesN/A4,302.40448.7998.82Price / CashN/A13.1935.6858.35Price / BookN/A39.278.165.60Net IncomeN/A-$90.99M$3.25B$265.26M7 Day PerformanceN/A-0.82%1.15%-0.14%1 Month PerformanceN/A4.14%8.25%6.08%1 Year PerformanceN/A179.01%29.18%24.22% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTPW60 Degrees PharmaceuticalsN/A$0.10+99.0%N/A+143.7%$0.00$665.45K0.002Gap UpATNFW180 Life SciencesN/A$0.01+3.1%N/A+38.2%$0.00N/A0.007Gap UpHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.26+8.5%N/A+140.6%$0.00N/A0.0080Positive NewsGap DownAPLMWApollomicsN/A$0.03+6.2%N/A+106.4%$0.00N/A0.0059Gap UpBCTXWBriaCell TherapeuticsN/A$0.04-4.9%N/A-79.9%$0.00N/A0.008Positive NewsShort Interest ↑Gap UpCDIOWCardio DiagnosticsN/A$0.01-1.4%N/A-67.6%$0.00$19.90K0.007Positive NewsShort Interest ↑Gap DownCELUWCelularityN/A$0.06+19.8%N/A+143.9%$0.00$54.22M0.00220Positive NewsGap DownHigh Trading VolumeCEROWCERo TherapeuticsN/A$0.02flatN/A-35.3%$0.00N/A0.008News CoveragePositive NewsShort Interest ↑Gap DownCINGWCingulateN/A$0.12-1.6%N/A+1,285.6%$0.00N/A0.0020Gap DownCLNNWCleneN/A$0.03-31.4%N/A+30.0%$0.00$350K0.00100Gap DownCOEPWCoeptis TherapeuticsN/A$0.03-7.0%N/A+24.9%$0.00$62.87K0.004Positive News Related Companies and Tools Related Companies ATNFW Alternatives DRTSW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTPW) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
